Cryptococcosis in the immunocompetent patient

Respiratory Care

Volumn 55, Issue 11, 2010, Pages 1499-1503

  Goldman, Jason D ^a   Vollmer, Michael E ^b   Luks, Andrew M ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Infectious Disease Doctors Medical Group   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ETIRACETAM; FLUCONAZOLE; FLUCYTOSINE; PHENYTOIN; ANTIFUNGAL AGENT;

ADULT; ANEMIA; ARTICLE; BACKACHE; BRAIN CYST; BRONCHOSCOPY; BRONCHUS INJURY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY HISTORY; GRANULOMATOUS INFLAMMATION; HEADACHE; HEMIANOPIA; HISTOPATHOLOGY; HUMAN; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; JAW PAIN; KIDNEY FAILURE; LACERATION; LUNG BIOPSY; LUNG LESION; MALE; MOUTH EXAMINATION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOPHOBIA; SEIZURE; SYNCOPE; THORAX RADIOGRAPHY; TONIC CLONIC SEIZURE; CRYPTOCOCCAL MENINGITIS; ISOLATION AND PURIFICATION; LUNG MYCOSIS; MICROBIOLOGY; RADIOGRAPHY;

ADULT; ANTIFUNGAL AGENTS; BRONCHOSCOPY; CRYPTOCOCCUS GATTII; HUMANS; IMMUNOCOMPETENCE; LUNG DISEASES, FUNGAL; MAGNETIC RESONANCE IMAGING; MALE; MENINGITIS, CRYPTOCOCCAL; SEIZURES;

EID: 79952109498     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004;101(49):17258-17263.
2. Iqbal N, DeBess EE, Wohrle R, Sun B, Nett RJ, Ahlquist AM, et al. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 2010;48(2):539-544.
3. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006;20(3):507-544;v-vi.
4. Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, Heitman J, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 2009;15(8):1185-1191.
5. Campbell GD. Primary pulmonary cryptococcosis. Am Rev Respir Dis 1966;94(2):236-243.
6. Huang CJ, Yang MC, Ueng SH. Large cryptococcoma mimicking lung cancer in an HIV-negative, type 2 diabetic patient. J Thorac Imaging 2005;20(2):115-117.
7. Piyavisetpat N, Chaowanapanja P. Radiographic manifestations of pulmonary cryptococcosis. J Med Assoc Thai 2005;88(11):1674-1679.
8. Karnak D, Avery RK, Gildea TR, Sahoo D, Mehta AC. Endobronchial fungal disease: an under-recognized entity. Respiration 2007; 74(1):88-104.
9. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995;20(3):611-616.
10. Baughman RP, Rhodes JC, Dohn MN, Henderson H, Frame PT. Detection of cryptococcal antigen in bronchoalveolar lavage fluid: a prospective study of diagnostic utility. Am Rev Respir Dis 1992; 145(5):1226-1229.
11. Jarvis JN, Harrison TS. Pulmonary cryptococcosis. Semin Respir Crit Care Med 2008;29(2):141-150.
12. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010;50(3):291-322.